HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Advantages in the use of L-asparaginase-albumin polymer as an antitumor agent.

Abstract
Polymeric conjugates of L-asparaginase and an excess of homologous albumin were compared with free L-asparaginase for antitumor activity using a mouse model 6C3HED lymphosarcoma and a human pancreatic tumor cell line, PANC-1. The asparaginase-albumin polymer is more resistant to proteolytic degradation compared to equivalent amounts of free enzyme and is more effective as an antitumor agent in prolonging survival of C3H/HeJ mice receiving 6C3HED lymphosarcoma. In terms of antitumor activity, the enzyme is approximately 20 times more effective, compared to free enzyme, when given in polymeric form with albumin. Similarly, the polymeric form of L-asparaginase is more effective in inhibiting cell growth of human pancreatic tumor cells grown in tissue culture. The increased effectiveness of the polymeric form of L-asparaginase is probably related to its resistance to biodegradation. The use of cell surface-specific monoclonal antibodies to target the polymer to tumor cells is also demonstrated.
AuthorsM J Poznansky, M Shandling, M A Salkie, J F Elliott, E Lau
JournalCancer research (Cancer Res) Vol. 42 Issue 3 Pg. 1020-5 (Mar 1982) ISSN: 0008-5472 [Print] United States
PMID6895861 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Albumins
  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Polymers
  • Asparaginase
Topics
  • Albumins (pharmacology)
  • Animals
  • Antibodies, Monoclonal (immunology)
  • Antineoplastic Agents (pharmacology)
  • Asparaginase (pharmacology)
  • Biotransformation
  • Cell Division (drug effects)
  • Cell Line
  • Cell Membrane (immunology)
  • Cell Survival (drug effects)
  • Humans
  • Lymphoma, Non-Hodgkin (pathology)
  • Mice
  • Pancreatic Neoplasms (immunology, pathology)
  • Polymers (chemical synthesis, pharmacology)
  • Sarcoma, Experimental (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: